Inmune Bio, Inc. (35) | Uncategorized (12)

Recent Contracts

Form of Option Agreement between the Company and Non-Employee Directors and consultants (Filed With SEC on March 24, 2022)
Form of Option Agreement for Employees of the Company (Filed With SEC on March 24, 2022)
Description of Securities of INmune Bio, Inc (Filed With SEC on March 3, 2022)
Amendment No. 1 to Rights Agreement, dated as of December 20, 2021, between INmune Bio Inc. and Vstock Transfer, LLC (Filed With SEC on December 21, 2021)
Form of Option Agreement between the Company and Non-Employee Directors (Filed With SEC on June 24, 2021)
Form of Option Agreement for Employees of the Company (Filed With SEC on June 24, 2021)
Option Cancellation Agreement between INmune Bio Inc. and Xencor, Inc (Filed With SEC on June 15, 2021)
Form of agreement between INmune Bio Inc. and National Securities Corporation, dated March 29, 2021 (Filed With SEC on March 29, 2021)
Rights Agreement, dated as of December 30, 2020, by and between INmune Bio Inc. and VStock Transfer, LLC (Filed With SEC on January 4, 2021)
Rights Agreement, dated as of December 30, 2020, by and between INmune Bio Inc. and VStock Transfer, LLC (Filed With SEC on December 30, 2020)
Award Agreement dated as of February 4, 2020 (Filed With SEC on February 10, 2020)
Award Letter dated as of February 22, 2019 from the Alzheimers Association to INmune Bio, Inc (Filed With SEC on February 28, 2019)